Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s software/display footer revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check51 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision notes updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check87 days agoChange DetectedAdded Revision: v3.4.2 to the site. The prior 3.4.1 notice about government funding and operating status was removed, indicating an update to the page template.SummaryDifference0.4%

- Check94 days agoChange DetectedA government funding status notice was added to the page. The page revision was updated to v3.4.1, replacing the previous v3.4.0 reference.SummaryDifference0.4%

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.